Identification and distribution of Rhipicephalus microplus in selected high-cattle density districts in Uganda: signaling future demand for novel tick control approaches.
Autorzy:
Etiang P; College of Veterinary Medicine, Animal Resources and Biosecurity (COVAB), Makerere University, P.O. Box 7062, Kampala, Uganda.; Faculty of Agriculture and Animal Sciences, Busitema University, P.O. Box 236, Tororo, Uganda. Atim SA; College of Veterinary Medicine, Animal Resources and Biosecurity (COVAB), Makerere University, P.O. Box 7062, Kampala, Uganda.; Ministry of Agriculture, Animal Industry and Fisheries, P.O. Box 102, Entebbe, Uganda. Nkamwesiga J; College of Veterinary Medicine, Animal Resources and Biosecurity (COVAB), Makerere University, P.O. Box 7062, Kampala, Uganda. Nalumenya D; College of Veterinary Medicine, Animal Resources and Biosecurity (COVAB), Makerere University, P.O. Box 7062, Kampala, Uganda. Byaruhanga C; National Agricultural Research Organization, P.O. Box 259, Entebbe, Uganda.; Vectors and Vector-Borne Diseases Research Programme, Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort, 0110, South Africa. Odongo S; College of Veterinary Medicine, Animal Resources and Biosecurity (COVAB), Makerere University, P.O. Box 7062, Kampala, Uganda. Vudriko P; College of Veterinary Medicine, Animal Resources and Biosecurity (COVAB), Makerere University, P.O. Box 7062, Kampala, Uganda. Ademun AR; Ministry of Agriculture, Animal Industry and Fisheries, P.O. Box 102, Entebbe, Uganda. Biryomumaisho S; College of Veterinary Medicine, Animal Resources and Biosecurity (COVAB), Makerere University, P.O. Box 7062, Kampala, Uganda. Erume J; College of Veterinary Medicine, Animal Resources and Biosecurity (COVAB), Makerere University, P.O. Box 7062, Kampala, Uganda. Masembe C; College of Natural Sciences (CONAS), Makerere University, P.O. Box 7062, Kampala, Uganda. ThomsonEC; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Muhanguzi D; College of Veterinary Medicine, Animal Resources and Biosecurity (COVAB), Makerere University, P.O. Box 7062, Kampala, Uganda. Tweyongyere R; College of Veterinary Medicine, Animal Resources and Biosecurity (COVAB), Makerere University, P.O. Box 7062, Kampala, Uganda. .
Pokaż więcej
Źródło:
BMC veterinary research [BMC Vet Res] 2024 Mar 25; Vol. 20 (1), pp. 119. Date of Electronic Publication: 2024 Mar 25.
The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis.
Autorzy:
Pascall DJ; MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.; Joint Universities Pandemic and Epidemiological Research (JUNIPER) Consortium, United Kingdom. Vink E; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.; NHS Lothian, Edinburgh, United Kingdom. Blacow R; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom. Bulteel N; NHS Fife, Kirkcaldy, Fife, United Kingdom. Campbell A; NHS Lothian, Edinburgh, United Kingdom. Campbell R; NHS Lothian, Edinburgh, United Kingdom. Clifford S; NHS Lothian, Edinburgh, United Kingdom. Davis C; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. da Silva Filipe A; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. El Sakka N; NHS Grampian, Aberdeen, United Kingdom. Fjodorova L; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom. Forrest R; NHS Fife, Kirkcaldy, Fife, United Kingdom. Goldstein E; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom. Gunson R; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom. Haughney J; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom. Holden MTG; Public Health Scotland, Edinburgh, United Kingdom.; School of Medicine, University of St Andrews, St Andrews, Fife, United Kingdom. Honour P; NHS Borders, Melrose, Scottish Borders, United Kingdom. Hughes J; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. James E; NHS Borders, Melrose, Scottish Borders, United Kingdom. Lewis T; NHS Lothian, Edinburgh, United Kingdom. Lycett S; The Roslin Institute, University of Edinburgh, Midlothian, United Kingdom. MacLean O; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. McHugh M; NHS Lothian, Edinburgh, United Kingdom. Mollett G; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom. Onishi Y; NHS Grampian, Aberdeen, United Kingdom. Parcell B; School of Life Sciences, University of Dundee, Dundee, United Kingdom. Ray S; School of Mathematics and Statistics, University of Glasgow, Glasgow, United Kingdom. Robertson DL; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Shabaan S; Public Health Scotland, Edinburgh, United Kingdom. Shepherd JG; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Smollett K; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Templeton K; NHS Lothian, Edinburgh, United Kingdom. Wastnedge E; NHS Lothian, Edinburgh, United Kingdom. Wilkie C; School of Mathematics and Statistics, University of Glasgow, Glasgow, United Kingdom. Williams T; NHS Lothian, Edinburgh, United Kingdom.; Royal Hospital for Children and Young People, University of Edinburgh, Edinburgh, United Kingdom. ThomsonEC; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Prevalence of Crimean-Congo haemorrhagic fever in livestock following a confirmed human case in Lyantonde district, Uganda.
Autorzy:
Atim SA; College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB), Makerere University, Kampala, Uganda.; Centre of Virus Research (CVR), University of Glasgow, Glasgow, UK.; Ministry of Agriculture, Animal Industry and Fisheries, Entebbe, Uganda. Niebel M; Centre of Virus Research (CVR), University of Glasgow, Glasgow, UK. Ashraf S; Centre of Virus Research (CVR), University of Glasgow, Glasgow, UK. Vudriko P; College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB), Makerere University, Kampala, Uganda. Odongo S; College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB), Makerere University, Kampala, Uganda. Balinandi S; Department of Emerging, Re-Emerging and Arbovirus Infections, Uganda Virus Research Institute, Entebbe, Uganda. Aber P; Case Western Research Collaboration, Makerere University, Kampala, Uganda. Bameka R; Lyantonde District Local Government, Lyantonde, Uganda. Ademun AR; Ministry of Agriculture, Animal Industry and Fisheries, Entebbe, Uganda. Masembe C; College of Natural Resources (CoNAS), Makerere University, Kampala, Uganda. Tweyongyere R; College of Veterinary Medicine, Animal Resources and Biosecurity (CoVAB), Makerere University, Kampala, Uganda. ThomsonEC; Centre of Virus Research (CVR), University of Glasgow, Glasgow, UK. emma.thomson@glasgow.ac.uk.; MRC-University of Glasgow Centre for Virus Research, Stoker Building, 464 Bearsden Road, Glasgow, G61 1QH, UK. emma.thomson@glasgow.ac.uk.
Pokaż więcej
Źródło:
Parasites & vectors [Parasit Vectors] 2023 Jan 07; Vol. 16 (1), pp. 7. Date of Electronic Publication: 2023 Jan 07.
Characterisation of a Hepatitis C Virus Subtype 2a Cluster in Scottish PWID with a Suboptimal Response to Glecaprevir/Pibrentasvir Treatment.
Autorzy:
Shah R; Thomson Group, College of Medical, Veterinary & Life Sciences, MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. Barclay ST; NHS Greater Glasgow & Clyde, Departments of Hepatology and Virology, Glasgow Royal Infirmary, Glasgow G4 0SF, UK. Peters ES; NHS Greater Glasgow & Clyde, Departments of Hepatology and Virology, Glasgow Royal Infirmary, Glasgow G4 0SF, UK. Fox R; NHS Greater Glasgow & Clyde, Departments of Hepatology and Virology, Glasgow Royal Infirmary, Glasgow G4 0SF, UK. Gunson R; Thomson Group, College of Medical, Veterinary & Life Sciences, MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK.; NHS Greater Glasgow & Clyde, Departments of Hepatology and Virology, Glasgow Royal Infirmary, Glasgow G4 0SF, UK. Bradley-Stewart A; NHS Greater Glasgow & Clyde, Departments of Hepatology and Virology, Glasgow Royal Infirmary, Glasgow G4 0SF, UK. Shepherd SJ; NHS Greater Glasgow & Clyde, Departments of Hepatology and Virology, Glasgow Royal Infirmary, Glasgow G4 0SF, UK. MacLean A; NHS Greater Glasgow & Clyde, Departments of Hepatology and Virology, Glasgow Royal Infirmary, Glasgow G4 0SF, UK. Tong L; Thomson Group, College of Medical, Veterinary & Life Sciences, MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. van Vliet VJE; Thomson Group, College of Medical, Veterinary & Life Sciences, MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. Ngan Chiu Bong M; Thomson Group, College of Medical, Veterinary & Life Sciences, MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. Filipe A; Thomson Group, College of Medical, Veterinary & Life Sciences, MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. ThomsonEC; Thomson Group, College of Medical, Veterinary & Life Sciences, MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK.; NHS Greater Glasgow & Clyde, Departments of Hepatology and Virology, Glasgow Royal Infirmary, Glasgow G4 0SF, UK. Davis C; Thomson Group, College of Medical, Veterinary & Life Sciences, MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Jul 29; Vol. 14 (8). Date of Electronic Publication: 2022 Jul 29.
A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmission.
Autorzy:
Stockdale AJ; Malawi-Liverpool-Wellcome Trust Programme, Blantyre, Malawi.; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK. Kreuels B; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine and 1st Department of Medicine, University Medical Centre, Hamburg-Eppendorf, Hamburg, Germany.; Kamuzu University of Health Sciences, Blantyre, Malawi. Shawa IT; Malawi-Liverpool-Wellcome Trust Programme, Blantyre, Malawi.; Kamuzu University of Health Sciences, Blantyre, Malawi. Meiring JE; Malawi-Liverpool-Wellcome Trust Programme, Blantyre, Malawi.; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Thindwa D; Malawi-Liverpool-Wellcome Trust Programme, Blantyre, Malawi.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. Silungwe NM; Malawi-Liverpool-Wellcome Trust Programme, Blantyre, Malawi. Chetcuti K; Malawi-Liverpool-Wellcome Trust Programme, Blantyre, Malawi.; Kamuzu University of Health Sciences, Blantyre, Malawi. Joekes E; Malawi-Liverpool-Wellcome Trust Programme, Blantyre, Malawi. Mbewe M; Malawi-Liverpool-Wellcome Trust Programme, Blantyre, Malawi. Mbale B; Malawi-Liverpool-Wellcome Trust Programme, Blantyre, Malawi. Patel P; Malawi-Liverpool-Wellcome Trust Programme, Blantyre, Malawi. Kachala R; Malawi Ministry of Health, Capitol Hill, Lilongwe, Malawi. Patel PD; Malawi-Liverpool-Wellcome Trust Programme, Blantyre, Malawi. Malewa J; Kamuzu University of Health Sciences, Blantyre, Malawi.; Department of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi. Finch P; Kamuzu University of Health Sciences, Blantyre, Malawi.; Department of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi. Davis C; MRC - University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK. Shah R; MRC - University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK. Tong L; MRC - University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK. da Silva Filipe A; MRC - University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK. ThomsonEC; MRC - University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK. Geretti AM; Department of Infectious Diseases, Fondazione PTV, Faculty of Medicine, University of Rome Tor Vergata, Rome, Italy. Gordon MA; Malawi-Liverpool-Wellcome Trust Programme, Blantyre, Malawi.; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.; Kamuzu University of Health Sciences, Blantyre, Malawi.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2022 Apr; Vol. 29 (4), pp. 252-262. Date of Electronic Publication: 2022 Feb 09.
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.
Autorzy:
Davis C; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom. Logan N; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom. Tyson G; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom. Orton R; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom. Harvey WT; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom. Perkins JS; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom. Mollett G; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom. Blacow RM; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom. Peacock TP; Department of Infectious Disease, Imperial College London, London, United Kingdom. Barclay WS; Department of Infectious Disease, Imperial College London, London, United Kingdom. Cherepanov P; The Francis Crick Institute, London, United Kingdom. Palmarini M; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom. Murcia PR; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom. Patel AH; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom. Robertson DL; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom. Haughney J; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom. ThomsonEC; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom. Willett BJ; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2.
Autorzy:
Szemiel AM; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Merits A; Institute of Technology, University of Tartu, Tartu, Estonia. Orton RJ; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. MacLean OA; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Pinto RM; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Wickenhagen A; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Lieber G; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Turnbull ML; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Wang S; Institute of Technology, University of Tartu, Tartu, Estonia. Furnon W; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Suarez NM; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Mair D; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. da Silva Filipe A; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Willett BJ; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Wilson SJ; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Patel AH; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. ThomsonEC; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Palmarini M; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Kohl A; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. Stewart ME; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2021 Sep 17; Vol. 17 (9), pp. e1009929. Date of Electronic Publication: 2021 Sep 17 (Print Publication: 2021).
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy.
Autorzy:
Smith DA; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK. Bradshaw D; National Infection Service, Public Health England, London, UK. Mbisa JL; National Infection Service, Public Health England, London, UK. Manso CF; National Infection Service, Public Health England, London, UK. Bibby DF; National Infection Service, Public Health England, London, UK. Singer JB; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK. ThomsonEC; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK. da Silva Filipe A; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK. Aranday-Cortes E; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK. Ansari MA; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK. Brown A; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK. Hudson E; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK. Benselin J; NIHR Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK. Healy B; Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK. Troke P; Gilead Sciences Ltd, London, UK. McLauchlan J; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK. Barnes E; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK. Irving WL; NIHR Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2021 Sep; Vol. 28 (9), pp. 1256-1264. Date of Electronic Publication: 2021 Jun 08.
SARS-CoV-2 within-host diversity and transmission.
Autorzy:
Lythgoe KA; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK. .; Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK. Hall M; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK. . Ferretti L; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK. de Cesare M; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK.; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Old Road Campus, Oxford OX3 7BN, UK. MacIntyre-Cockett G; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK.; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Old Road Campus, Oxford OX3 7BN, UK. Trebes A; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Old Road Campus, Oxford OX3 7BN, UK. Andersson M; Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK.; Division of Medical Virology, Stellenbosch University, Stellenbosch, South Africa. Otecko N; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK. Wise EL; Hampshire Hospitals NHS Foundation Trust, Basingstoke and North Hampshire Hospital, Basingstoke RG24 9NA, UK.; School of Biosciences and Medicine, University of Surrey, Guildford GU2 7XH, UK. Moore N; Hampshire Hospitals NHS Foundation Trust, Basingstoke and North Hampshire Hospital, Basingstoke RG24 9NA, UK. Lynch J; Hampshire Hospitals NHS Foundation Trust, Basingstoke and North Hampshire Hospital, Basingstoke RG24 9NA, UK. Kidd S; Hampshire Hospitals NHS Foundation Trust, Basingstoke and North Hampshire Hospital, Basingstoke RG24 9NA, UK. Cortes N; Hampshire Hospitals NHS Foundation Trust, Basingstoke and North Hampshire Hospital, Basingstoke RG24 9NA, UK.; Gibraltar Health Authority, Gibraltar, UK. Mori M; School of Medicine, University of Southampton, Southampton SO17 1BJ, UK. Williams R; Hampshire Hospitals NHS Foundation Trust, Basingstoke and North Hampshire Hospital, Basingstoke RG24 9NA, UK. Vernet G; Hampshire Hospitals NHS Foundation Trust, Basingstoke and North Hampshire Hospital, Basingstoke RG24 9NA, UK. Justice A; Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK. Green A; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Old Road Campus, Oxford OX3 7BN, UK. Nicholls SM; Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK. Ansari MA; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, UK. Abeler-Dörner L; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK. Moore CE; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK. Peto TEA; Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK.; Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK. Eyre DW; Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK.; Big Data Institute, Nuffield Department of Public Health, University of Oxford, Old Road Campus, Oxford OX3 7FL, UK. Shaw R; Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK. Simmonds P; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, UK. Buck D; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Old Road Campus, Oxford OX3 7BN, UK. Todd JA; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Old Road Campus, Oxford OX3 7BN, UK. Connor TR; Pathogen Genomics Unit, Public Health Wales Microbiology, Cardiff CF10 4BZ, UK.; Cardiff University School of Biosciences, Cardiff University, Cardiff CF10 3AX, UK. Ashraf S; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. da Silva Filipe A; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. Shepherd J; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. ThomsonEC; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. Bonsall D; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK.; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Old Road Campus, Oxford OX3 7BN, UK.; Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK. Fraser C; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK.; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Old Road Campus, Oxford OX3 7BN, UK.; Wellcome Sanger Institute, Cambridge CB10 1SA, UK. Golubchik T; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK. .; Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK.
A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research.
Autorzy:
Rihn SJ; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Merits A; Institute of Technology, University of Tartu, Tartu, Estonia. Bakshi S; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Turnbull ML; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Wickenhagen A; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Alexander AJT; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Baillie C; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Brennan B; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Brown F; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Brunker K; Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom. Bryden SR; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Burness KA; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Carmichael S; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Cole SJ; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Cowton VM; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Davies P; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Davis C; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. De Lorenzo G; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Donald CL; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Dorward M; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Dunlop JI; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Elliott M; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Fares M; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. da Silva Filipe A; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Freitas JR; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia. Furnon W; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Gestuveo RJ; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.; Division of Biological Sciences, College of Arts and Sciences, University of the Philippines Visayas, Miagao, Iloilo, Philippines. Geyer A; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Giesel D; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Goldfarb DM; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Goodman N; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Gunson R; West of Scotland Specialist Virology Centre, Glasgow, United Kingdom. Hastie CJ; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Herder V; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Hughes J; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Johnson C; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Johnson N; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Kohl A; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Kerr K; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Leech H; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Lello LS; Institute of Technology, University of Tartu, Tartu, Estonia. Li K; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Lieber G; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Liu X; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia. Lingala R; Indian Immunologicals Ltd (IIL), Rakshapuram, Gachibowli Post, Hyderabad Telangana, India. Loney C; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Mair D; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. McElwee MJ; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. McFarlane S; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Nichols J; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Nomikou K; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Orr A; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Orton RJ; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Palmarini M; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Parr YA; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Pinto RM; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Raggett S; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Reid E; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Robertson DL; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Royle J; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Cameron-Ruiz N; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Shepherd JG; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Smollett K; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Stewart DG; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Stewart M; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Sugrue E; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Szemiel AM; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Taggart A; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. ThomsonEC; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Tong L; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Torrie LS; Drug Discovery Unit (DDU), Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Toth R; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Varjak M; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Wang S; Institute of Technology, University of Tartu, Tartu, Estonia. Wilkinson SG; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Wyatt PG; Drug Discovery Unit (DDU), Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Zusinaite E; Institute of Technology, University of Tartu, Tartu, Estonia. Alessi DR; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom. Patel AH; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Zaid A; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.; School of Medical Sciences, Griffith University, Gold Coast, Queensland, Australia. Wilson SJ; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom. Mahalingam S; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2021 Feb 25; Vol. 19 (2), pp. e3001091. Date of Electronic Publication: 2021 Feb 25 (Print Publication: 2021).
Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care.
Autorzy:
Bosworth A; Public Health England, Manor Farm Road, Porton Down, Salisbury, UK.; Clinical Virology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute for Health Research, Liverpool, UK. Rickett NY; Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute for Health Research, Liverpool, UK.; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK. Dong X; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK. Ng LFP; Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute for Health Research, Liverpool, UK.; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.; Infectious Disease Horizontal Technology Centre (ID HTC), A*STAR, Singapore, Singapore. García-Dorival I; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK. Matthews DA; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK. Fletcher T; Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute for Health Research, Liverpool, UK.; Liverpool School of Tropical Medicine, Liverpool, UK. Jacobs M; Department of Infection, Royal Free London NHS Foundation Trust, London, UK. ThomsonEC; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK. emma.thomson@glasgow.ac.uk. Carroll MW; Public Health England, Manor Farm Road, Porton Down, Salisbury, UK. .; Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute for Health Research, Liverpool, UK. .; Nufield Department of Medicine, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK. . Hiscox JA; Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute for Health Research, Liverpool, UK. .; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK. .; Infectious Disease Horizontal Technology Centre (ID HTC), A*STAR, Singapore, Singapore. .
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2021 Jan 11; Vol. 13 (1), pp. 5. Date of Electronic Publication: 2021 Jan 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Autorzy:
Hanna CR; CRUK Clinical Trials Unit, University of Glasgow, Glasgow, UK.; NHS Greater Glasgow & Clyde, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. Blyth KG; NHS Greater Glasgow & Clyde, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. Burley G; University of Strathclyde, Glasgow, UK. Carmichael S; NHS Greater Glasgow & Clyde, Glasgow, UK. Evans C; CRUK Clinical Trials Unit, University of Glasgow, Glasgow, UK. Hinsley S; CRUK Clinical Trials Unit, University of Glasgow, Glasgow, UK. Khadra I; University of Strathclyde, Glasgow, UK. Khoo S; Department of Pharmacology, University of Liverpool, Liverpool, UK. Lewsley LA; CRUK Clinical Trials Unit, University of Glasgow, Glasgow, UK. Jones RR; CRUK Clinical Trials Unit, University of Glasgow, Glasgow, UK.; NHS Greater Glasgow & Clyde, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. Sharma R; Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK. Taladriz-Sender A; University of Strathclyde, Glasgow, UK. ThomsonEC; MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK. Scott JT; NHS Greater Glasgow & Clyde, Glasgow, UK. .; MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK. .
Pokaż więcej
Źródło:
Trials [Trials] 2020 Nov 19; Vol. 21 (1), pp. 935. Date of Electronic Publication: 2020 Nov 19.
Transmission of hepatitis C virus in HIV-positive and PrEP-using MSM in England.
Autorzy:
Bradshaw D; Department of HIV and Sexual Health, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK. Vasylyeva TI; Department of Zoology, University of Oxford, Oxford, UK. Davis C; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK. Pybus OG; Department of Zoology, University of Oxford, Oxford, UK. Thézé J; Department of Zoology, University of Oxford, Oxford, UK. ThomsonEC; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK. Martinello M; Kirby Institute, University of New South Wales, Sydney, Australia. Matthews GV; Kirby Institute, University of New South Wales, Sydney, Australia. Burholt R; Brighton and Sussex University Hospitals NHS Trust, Brighton, UK. Gilleece Y; Brighton and Sussex University Hospitals NHS Trust, Brighton, UK. Cooke GS; Imperial College London, London, UK. Page EE; Leeds Teaching Hospitals NHS Trust, Leeds, UK. Waters L; Mortimer Market Centre, London, UK. Nelson M; Department of HIV and Sexual Health, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2020 Jul; Vol. 27 (7), pp. 721-730. Date of Electronic Publication: 2020 Mar 12.
Interpreting Viral Deep Sequencing Data with GLUE.
Autorzy:
Singer JB; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. . ThomsonEC; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. Emma.Thomson@glasgow.ac.uk. Hughes J; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. . Aranday-Cortes E; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. . McLauchlan J; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. . da Silva Filipe A; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. . Tong L; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. . Manso CF; Virus Reference Department, National Infection Service, Public Health England, Colindale, London NW9 5EQ, UK. . Gifford RJ; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. . Robertson DL; MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. . Barnes E; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. . Ansari MA; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. . Mbisa JL; Virus Reference Department, National Infection Service, Public Health England, Colindale, London NW9 5EQ, UK. . Bibby DF; Virus Reference Department, National Infection Service, Public Health England, Colindale, London NW9 5EQ, UK. . Bradshaw D; Virus Reference Department, National Infection Service, Public Health England, Colindale, London NW9 5EQ, UK. . Smith D; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. .
Pokaż więcej
Źródło:
Viruses [Viruses] 2019 Apr 03; Vol. 11 (4). Date of Electronic Publication: 2019 Apr 03.
GLUE: a flexible software system for virus sequence data.
Autorzy:
Singer JB; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, UK. . ThomsonEC; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, UK. McLauchlan J; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, UK. Hughes J; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, UK. Gifford RJ; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, UK. .
Pokaż więcej
Źródło:
BMC bioinformatics [BMC Bioinformatics] 2018 Dec 18; Vol. 19 (1), pp. 532. Date of Electronic Publication: 2018 Dec 18.
Quasispecies Changes with Distinctive Point Mutations in the Hepatitis C Virus Internal Ribosome Entry Site (IRES) Derived from PBMCs and Plasma.
Autorzy:
Mercuri L; Hepatology Section, Division of Medicine, Faculty of Medicine, Imperial College, London, UK. ThomsonEC; University of Glasgow MRC Centre for Virus Research, Glasgow, UK. Hughes J; University of Glasgow MRC Centre for Virus Research, Glasgow, UK. Karayiannis P; University of Nicosia Medical School, Nicosia, Cyprus.
Pokaż więcej
Źródło:
Advances in virology [Adv Virol] 2018 Nov 19; Vol. 2018, pp. 4835252. Date of Electronic Publication: 2018 Nov 19 (Print Publication: 2018).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
